FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:674 September 7, 1995 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

(Contemporary Biomedicine.) Edited by Carleton T. Garrett and Stewart Sell. 484 pp. Totowa, N.J., Humana Press, 1995. $125. ISBN 0-89603-210-8.

The field of tumor markers is fast-moving and littered with hopefuls and might-have-beens. Only a handful of markers have passed successfully from study in the basic laboratory to common clinical use. Earlier studies dealt predominantly with protein markers, but new genetic markers are now emerging because of large recent gains in understanding the genetic progression of many common neoplasms. There is a great need to identify new markers that will be useful for early detection and estimation of prognosis.

In this book the editors have tried to develop a comprehensive catalogue of tumor markers in many types of cancers. This . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.